pharmaceutical-technologyAugust 21, 2017
Tag: Guanhao Biotech , Cancer Genetics , Alvogen
M&As this week: Guanhao Biotech, Cancer Genetics, Alvogen - Pharmaceutical Technology
Chinese biotechnology company Guanhao Biotech plans to acquire a 53.4% stake in two pharmaceutical companies based in China for CNY266m ($39.95m).
US-based pharmaceutical company Cancer Genetics Inc (CGI) plans to acquire Australian preclinical oncology services provider vivoPharm for $12m. The acquisition is expected to strengthen CGI’s business.
South Korean pharmaceutical company Alvogen plans to acquire Russian pharmaceutical firm Omega Bittner from Irish healthcare company Perrigo Company.
The acquisition will strengthen Alvogen’s business in Russia.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: